Medibank Private logo

MPL - Medibank Private Share Price

A$2.9 -0.0  -1.4%

Last Trade - 15/01/21

Large Cap
Market Cap £4.54bn
Enterprise Value £4.10bn
Revenue £3.85bn
Position in Universe 75th / 1843
Unlock MPL Revenue
Relative Strength (%)
1m +1.81%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -13.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
6,670 6,805 6,940 6,569 6,763 6,777 7,024 7,290 +0.3%
+49.2 +46.4 +7.6 -5.4 +3.7 -26.2 +15.9 +4.38
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 30 June 2020, MedibankPrivate Ltd revenues increased less than 1% to A$6.78B. Netincome before extraordinary items decreased 28% toA$315.6M. Revenues reflect Health Insurance segmentincrease of 1% to A$6.55B, Medibank Health segment increaseof 17% to A$270M. Net income was partially offset by HealthInsurance segment income decrease of 13% to A$470.6M,Unallocated segment loss increase of 4% to A$37.4M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


MPL Revenue Unlock MPL Revenue

Net Income

MPL Net Income Unlock MPL Revenue

Normalised EPS

MPL Normalised EPS Unlock MPL Revenue

PE Ratio Range

MPL PE Ratio Range Unlock MPL Revenue

Dividend Yield Range

MPL Dividend Yield Range Unlock MPL Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
MPL EPS Forecasts Unlock MPL Revenue
Profile Summary

Medibank Private Ltd is an Australia-based healthcare company. The Company provides private health insurance and health solutions. Its segments include Health Insurance and Medibank Health. Health Insurance segment offers private health insurance products, including hospital cover and ancillary cover, as stand-alone products or packaged products that combine the two. Hospital cover provides members with health cover for hospital treatments, whereas ancillary cover provides members with health cover for healthcare services such as dental, optical and physiotherapy. The segment also offers health insurance products to overseas visitors and overseas students. Medibank Health segment offers a range of activities including contracting with government and corporate customers to provide health management services, as well as providing a range of telehealth services in Australia. In addition, it distributes travel, life and pet insurance products on behalf of other insurers.

Last Annual June 30th, 2020
Last Interim June 30th, 2020
Incorporated December 1, 1997
Public Since November 25, 2014
No. of Shareholders: n/a
No. of Employees: 3,536
Sector Financials
Industry Insurance
Index S&P/ASX 50 , S&P/ASX All Ordinaries , S&P/ASX 100 , S&P/ASX 200 , S&P/ASX 300 , FTSE Developed Asia Pacific , FTSE Developed Asia Pacific Ex Japan ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 2,754,003,240
Free Float (0.0%)
Eligible for
MPL Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for MPL
Upcoming Events for MPL
Saturday 20th February, 2021 Estimate
Half Year 2021 Medibank Private Ltd Earnings Release
Frequently Asked Questions for Medibank Private
What is the Medibank Private share price?

As of 15/01/21, shares in Medibank Private are trading at A$2.9, giving the company a market capitalisation of £4.54bn. This share price information is delayed by 15 minutes.

How has the Medibank Private share price performed this year?

Shares in Medibank Private are currently trading at A$2.9 and the price has moved by -12.39% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Medibank Private price has moved by -10.23% over the past year.

What are the analyst and broker recommendations for Medibank Private?

Of the analysts with advisory recommendations for Medibank Private, there are there are currently 1 "buy" , 5 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Medibank Private is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Medibank Private next release its financial results?

Medibank Private is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Medibank Private dividend yield?

The Medibank Private dividend yield is 4.14% based on the trailing twelve month period.

Does Medibank Private pay a dividend?

Last year, Medibank Private paid a total dividend of 0.12, and it currently has a trailing dividend yield of 4.14%. Looking ahead, Medibank Private has not announced an ex-dividend date yet.

When does Medibank Private next pay dividends?

Medibank Private has yet to annouce their ex-dividend date. The historic dividend yield on Medibank Private shares is currently 4.14%.

How do I buy Medibank Private shares?

To buy shares in Medibank Private you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Medibank Private?

Shares in Medibank Private are currently trading at A$2.9, giving the company a market capitalisation of £4.54bn.

Where are Medibank Private shares listed? Where are Medibank Private shares listed?

Here are the trading details for Medibank Private:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: MPL
What kind of share is Medibank Private?

Based on an overall assessment of its quality, value and momentum, Medibank Private is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Medibank Private share price forecast 2021?

Shares in Medibank Private are currently priced at A$2.9. At that level they are trading at 3.83% discount to the analyst consensus target price of 0.00.

Analysts covering Medibank Private currently have a consensus Earnings Per Share (EPS) forecast of 0.137 for the next financial year.

How can I tell whether the Medibank Private share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medibank Private. Over the past six months, the relative strength of its shares against the market has been -14.29%. At the current price of A$2.9, shares in Medibank Private are trading at 3.25% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Medibank Private PE Ratio?

The Medibank Private PE ratio based on its reported earnings over the past 12 months is 24.53. The shares are currently trading at A$2.9.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Medibank Private?

Medibank Private's management team is headed by:

Anna Bligh - NID
David Fagan - NID
Peter Hodgett - NID
Andrew Wilson - OTH
Kylie Bishop - OTH
David Koczkar - OTH
Mei Ramsay - SEC
Craig Drummond - CEO
John Goodall - OTH
Michael Wilkins - NEC
Tracey Batten - NID
Mark Rogers - CFO
Who are the major shareholders of Medibank Private?

Here are the top five shareholders of Medibank Private based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 6.02% (165.8m shares)
Perpetual Investment Management Limited Investment Advisor/Hedge Fund
Percentage owned: 4.86% (133.7m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 3.22% (88.8m shares)
Schroder Investment Management (Singapore) Ltd. Investment Advisor/Hedge Fund
Percentage owned: 2.43% (67.0m shares)
Schroder Investment Management (Australia) Ltd. Investment Advisor
Percentage owned: 2.19% (60.3m shares)
Similar to MPL
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.